CNY 18.49
(-0.59%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.27 Billion CNY | 216.73% |
2022 | 402.01 Million CNY | -20.75% |
2021 | 507.24 Million CNY | 269.8% |
2020 | 137.16 Million CNY | -59.34% |
2019 | 337.37 Million CNY | -34.24% |
2018 | 513.01 Million CNY | 213.99% |
2017 | -450.07 Million CNY | 69.05% |
2016 | -1.45 Billion CNY | -3299.09% |
2015 | -42.78 Million CNY | 85.63% |
2014 | -297.64 Million CNY | -309.22% |
2013 | -72.73 Million CNY | 57.55% |
2012 | -171.32 Million CNY | -26.86% |
2011 | -135.05 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 3.11 Billion CNY | 144.52% |
2024 Q2 | 1.64 Billion CNY | -47.01% |
2024 Q3 | 5.25 Billion CNY | -4.58% |
2023 FY | 1.27 Billion CNY | 216.73% |
2023 Q1 | 1.98 Billion CNY | 392.62% |
2023 Q3 | 1.37 Billion CNY | 671.69% |
2023 Q4 | 1.27 Billion CNY | -7.48% |
2023 Q2 | 178.33 Million CNY | -91.0% |
2022 Q4 | 402.01 Million CNY | -62.34% |
2022 Q2 | 1.43 Billion CNY | -14.39% |
2022 Q1 | 1.67 Billion CNY | 230.57% |
2022 Q3 | 1.06 Billion CNY | -25.63% |
2022 FY | 402.01 Million CNY | -20.75% |
2021 FY | 507.24 Million CNY | 269.8% |
2021 Q1 | 2.35 Billion CNY | 1613.97% |
2021 Q2 | 2.13 Billion CNY | -9.12% |
2021 Q3 | 2.27 Billion CNY | 6.47% |
2021 Q4 | 507.24 Million CNY | -77.7% |
2020 Q4 | 137.16 Million CNY | -87.49% |
2020 Q1 | 1.25 Billion CNY | 272.8% |
2020 FY | 137.16 Million CNY | -59.34% |
2020 Q2 | 1.25 Billion CNY | -0.42% |
2020 Q3 | 1.09 Billion CNY | -12.43% |
2019 Q2 | 1.3 Billion CNY | 27.86% |
2019 FY | 337.37 Million CNY | -34.24% |
2019 Q4 | 337.37 Million CNY | -76.52% |
2019 Q3 | 1.43 Billion CNY | 9.84% |
2019 Q1 | 1.02 Billion CNY | 99.44% |
2018 Q1 | 434.89 Million CNY | 196.63% |
2018 Q4 | 513.01 Million CNY | -39.49% |
2018 FY | 513.01 Million CNY | 213.99% |
2018 Q3 | 847.8 Million CNY | 735.66% |
2018 Q2 | 101.45 Million CNY | -76.67% |
2017 Q4 | -450.07 Million CNY | -66.03% |
2017 FY | -450.07 Million CNY | 69.05% |
2017 Q3 | -271.08 Million CNY | 59.19% |
2017 Q2 | -664.17 Million CNY | 3.84% |
2017 Q1 | -690.66 Million CNY | 52.51% |
2016 FY | -1.45 Billion CNY | -3299.09% |
2016 Q4 | -1.45 Billion CNY | -45.16% |
2016 Q2 | -1.29 Billion CNY | -9.88% |
2016 Q1 | -1.18 Billion CNY | -2658.72% |
2016 Q3 | -1 Billion CNY | 22.75% |
2015 Q2 | 112.99 Million CNY | -29.57% |
2015 Q4 | -42.78 Million CNY | -112.11% |
2015 Q3 | 353.19 Million CNY | 212.56% |
2015 Q1 | 160.45 Million CNY | 153.91% |
2015 FY | -42.78 Million CNY | 85.63% |
2014 Q1 | 668.14 Million CNY | 1018.61% |
2014 Q3 | 428.23 Million CNY | 166.09% |
2014 Q4 | -297.64 Million CNY | -169.5% |
2014 FY | -297.64 Million CNY | -309.22% |
2014 Q2 | 160.93 Million CNY | -75.91% |
2013 FY | -72.73 Million CNY | 57.55% |
2013 Q4 | -72.73 Million CNY | 0.0% |
2012 FY | -171.32 Million CNY | -26.86% |
2011 FY | -135.05 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
China Meheco Group Co., Ltd. | 3.18 Billion CNY | 60.018% |
Liaoning Cheng Da Co., Ltd. | 8.1 Billion CNY | 84.283% |
Shanghai Pharmaceuticals Holding Co., Ltd | 29.08 Billion CNY | 95.622% |